Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2004
10/21/2004WO2004089423A2 Pharmico-gene theraphy of epithelial sodium channel associated disoders
10/21/2004WO2004089396A2 Anti-fungal peptidomimetics
10/21/2004WO2004089310A2 High-throughput assay for virus entry and drug screening
10/21/2004WO2004089302A2 Posh polypeptides, complexes and related methods
10/21/2004WO2004089295A2 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
10/21/2004WO2004089284A2 Targets for tumor growth inhibition
10/21/2004WO2004089190A2 Methods and probes for identifying vulnerable plaque
10/21/2004WO2004089187A2 Caries risk test for predicting and assessing the risk of disease
10/21/2004WO2004089184A2 NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
10/21/2004WO2004089182A2 Anti-retroviral analysis by mass spectrometry
10/21/2004WO2004081721A3 Method and apparatus for pattern identification in diploid dna sequence data
10/21/2004WO2004076641A8 New microorganism implicated in intestinal diseases, alzheimer’s disease and other diseases
10/21/2004WO2004075733A3 Construction of a deafness gene chip
10/21/2004WO2004074447A3 Compositions and methods for multiplex analysis of polynucleotides
10/21/2004WO2004072305A3 Atlastin
10/21/2004WO2004067778A3 Differentially expressed genes in large granular lymphocyte leukemia
10/21/2004WO2004067774A3 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
10/21/2004WO2004061085A3 Methods and apparatus for pathogen detection and analysis
10/21/2004WO2004054506A3 Methods and compositions for modulating nf-at transcription factor
10/21/2004WO2004044549A3 Universal tag assay
10/21/2004WO2004044246A3 Methods and compositions for detecting telomerase activity
10/21/2004WO2004040260A9 Raised surface assay plate
10/21/2004WO2004037200A3 Reticulocyte depletion signatures
10/21/2004WO2004036179A3 High throughput detection of glutathione s-transferase polymorphic alleles
10/21/2004WO2004035733A3 Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
10/21/2004WO2004034013A3 Genotoxicity analysis
10/21/2004WO2004025243A3 A method for the identification of drug targets
10/21/2004WO2004017062A8 The method and device for accelerating molecular hybridization by ultrasonic wave
10/21/2004WO2004016223A3 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity
10/21/2004WO2004013275A8 Stem cells derived from adipous tissue and differentiated cells derived from said cells
10/21/2004WO2004009032A3 Method and composition for treating and preventing hepatitis b infection and symptoms thereof
10/21/2004WO2003104478A3 Detection of rna structural elements
10/21/2004WO2003104431A3 Transgenic mammals expressing polyglutamine
10/21/2004WO2003095618A3 Identification of dysregulated genes in patients with multiple sclerosis
10/21/2004WO2003094838A3 Simple catalytic dna biosensors for ions based on color changes
10/21/2004WO2003093795A3 Device and method for analytical cell imaging
10/21/2004WO2003093793A3 Binary or polynary targeting and uses thereof
10/21/2004WO2003091835A3 Computationally targeted evolutionary design
10/21/2004WO2003085372A8 Biosensor membranes composed of polymers containing heterocyclic nitrogens
10/21/2004WO2003063689A3 Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
10/21/2004WO2003060081A3 Compositions and methods relating to endometrial specific genes and proteins
10/21/2004WO2003043631A3 Method for identification of tumor targeting enzymes
10/21/2004WO2003027638A8 Methods for detecting genetic mosaicisms using arrays
10/21/2004WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/21/2004WO2003025142A3 Novel nucleic acids and secreted polypeptides
10/21/2004WO2003010190A3 Peptide screen
10/21/2004WO1995027066A9 Dna encoding ubiquitin conjugating enzymes
10/21/2004US20040210961 Markerless transformation
10/21/2004US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS)
10/21/2004US20040210045 Nucleic acid labeling compounds
10/21/2004US20040210036 Designing amino acid sequence pools of manageable size, wherein individual peptides have the same net charge, same like net charge or neutral charge; peptide mimetic and kinase regulation
10/21/2004US20040209942 treating cancer and apoptosis-associated disorders using cell cycle checkpoint activation modulators; also screening for the modulators
10/21/2004US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis
10/21/2004US20040209380 Method for detecting a low abundance protein in a test sample
10/21/2004US20040209378 Method for measurement using sodium azide
10/21/2004US20040209355 Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
10/21/2004US20040209354 Multicompartment apparatus comprising intergratged pneumatic manifold and monolithic elastomer membrane for pumping, isolating, mixing, routing, merging, splitting, preparing and storing volumes of fluid
10/21/2004US20040209353 Apparatus which utilizes ribozymes, DNAzymes or catalytic antibodies to detect pathogens in blood products
10/21/2004US20040209349 Multicompartment apparatus for monitoring, evaluating and measuring concentration of microorganisms in fluids; mulltiplex detection
10/21/2004US20040209342 Comprises nucleotide sequences coding hydrolase for use in identifying modulators for treatment of diabetes and inflammatory diseases
10/21/2004US20040209340 Enzymatic degradation chains
10/21/2004US20040209332 Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences
10/21/2004US20040209328 Human tumor necrosis factor receptor TR16
10/21/2004US20040209319 Using high throughput assays which monitor phosphorylation and dephosphorylation of proteins to identify drugs for use as bactericides against infectious microorganisms
10/21/2004US20040209315 Methods to identify agents that increase or decrease UBP43 activity and methods for use of such agents
10/21/2004US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds
10/21/2004US20040209309 Compositions and methods for the specific detection of mammalian muscle proteins
10/21/2004US20040209308 Methods of assaying receptor activity and constructs useful in such methods
10/21/2004US20040209307 Using neural tissue injury, blood pressure regulation, inflammation and apoptosis related markers to diagnose and prognose cerebral vasospasms
10/21/2004US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
10/21/2004US20040209305 Epoxide polymer surfaces
10/21/2004US20040209302 Destabilized bioluminescent proteins
10/21/2004US20040209301 DNA chip having multi-layer film structure
10/21/2004US20040209300 Method for separating detection channels of a microscope system
10/21/2004US20040209299 In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
10/21/2004US20040209298 Preparing nucleotide sequences for use in generation of genomic and complimentary DNA libraries; genomics; genotyping and gene expression profiling; high throughput assay
10/21/2004US20040209296 Using transcription factor inhibitors and human leukocyte antigen antibodies to prevent and treatcell proliferfative disorders; genetic vaccines and antitumor agents
10/21/2004US20040209294 Method to produce a receptor chip using biotinylated protein
10/21/2004US20040209291 Using forward primers to monitor preferential gene expression; genomics
10/21/2004US20040209290 Prognosing survivability of patients with cell proliferative disorders based on tumor antigen gene expression profile; prognosing tumor recurrence
10/21/2004US20040209289 BTL-II nucleic acids, proteins, and antibodies
10/21/2004US20040209288 Using adjustments in leukotriene biosynthetic profile as tool to diagnosis and treat cardiovasular disorders
10/21/2004US20040209286 Comprises nucleotide sequences coding g protein coupled receptors for use in identifying modulators of sweet taste transduction; food processing; improving palatability of low-calorie beverages through the development of new artificial sweeteners
10/21/2004US20040209283 Using oligonucleotide templates and fluorescent dyes to screen for hepatitis c viral polymerase activity; viricides
10/21/2004US20040209282 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
10/21/2004US20040209281 Sample for manipulation by an optical tweezer, and a method and device to generate optically induced forces
10/21/2004US20040209280 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups
10/21/2004US20040209279 Comprises regulatory nucleotide sequences for generating animal model for liver disorders
10/21/2004US20040209278 Detection of modular polyketide synthase gene clusters
10/21/2004US20040209277 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation
10/21/2004US20040209276 Heat resistant polymerases for use in propagation and replication of nucleic acids
10/21/2004US20040209275 Using biomarker expression to detect and screen for degenerative bone diseases
10/21/2004US20040209274 Constructs for Gene Expression Analysis
10/21/2004US20040209270 Screening microorganism for ability to produce erythromycins for treatment of tumors and fungal infection; biosensors and macrolides
10/21/2004US20040209267 Method for identifying interaction between proteins and dna fragments of a genome
10/21/2004US20040209263 Selection of catalytic nucleic acids targeted to infectious agents
10/21/2004US20040209262 Microarray comprising immobilized peptide or nucleic acid probes for use in detection of preferential analytes in solution; disease diagnosis
10/21/2004US20040209261 Oligonucleotide pairs for multiplexed binding assays
10/21/2004US20040209260 Identifying regions of variation which characterizes specific genomic information; genetic mapping and disease diagnosis
10/21/2004US20040209259 amplifying dna samples using dideoxynucleotides as labels (to identify restriction fragment length polymorphisms and single strand conformational polymorphisms) to produce amplicons, then detecting hybridization; kits; Congenital Adrenal Hyperplasia